• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should we prescribe carbapenem for treating febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children with vesicoureteral reflux?

作者信息

Park Ji Young

机构信息

Department of Pediatrics, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.

出版信息

Clin Exp Pediatr. 2021 Jun;64(6):284-285. doi: 10.3345/cep.2020.01830. Epub 2021 Jan 5.

DOI:10.3345/cep.2020.01830
PMID:33445831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8181025/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/8181025/f2ab935deb07/cep-2020-01830f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/8181025/f2ab935deb07/cep-2020-01830f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a565/8181025/f2ab935deb07/cep-2020-01830f1.jpg

相似文献

1
Should we prescribe carbapenem for treating febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children with vesicoureteral reflux?对于患有膀胱输尿管反流的儿童，我们是否应该开具碳青霉烯类药物来治疗由产超广谱β-内酰胺酶肠杆菌科细菌引起的发热性尿路感染？
Clin Exp Pediatr. 2021 Jun;64(6):284-285. doi: 10.3345/cep.2020.01830. Epub 2021 Jan 5.
2
Reducing Carbapenem Exposure: Extended-Spectrum β-Lactamase Catheter-Associated Urinary Tract Infection Management.减少碳青霉烯类药物暴露：超广谱β-内酰胺酶导管相关尿路感染的管理
Crit Care Nurse. 2017 Oct;37(5):78-84. doi: 10.4037/ccn2017648.
3
Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a retrospective cohort study.产超广谱β-内酰胺酶肠杆菌科细菌所致上尿路感染不恰当抗生素治疗的长期结局：一项回顾性队列研究
Diagn Microbiol Infect Dis. 2017 Nov;89(3):222-229. doi: 10.1016/j.diagmicrobio.2017.07.011. Epub 2017 Jul 28.
4
Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.产超广谱β-内酰胺酶大肠埃希菌引起的儿童社区获得性上尿路感染增加及氟氧头孢和头孢美唑的疗效。
Clin Exp Nephrol. 2019 Nov;23(11):1306-1314. doi: 10.1007/s10157-019-01775-w. Epub 2019 Aug 19.
5
Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.接受预防性抗生素治疗的膀胱输尿管反流患儿社区获得性尿路感染的抗生素耐药模式
Pediatrics. 2008 Dec;122(6):1212-7. doi: 10.1542/peds.2007-2926.
6
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.降阶梯治疗至厄他培南用于治疗产超广谱β-内酰胺酶肠杆菌科细菌所致感染的疗效与安全性：一项开放标签随机对照试验
BMC Infect Dis. 2017 Mar 1;17(1):183. doi: 10.1186/s12879-017-2284-1.
7
Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.头孢吡肟与碳青霉烯类药物治疗产超广谱β-内酰胺酶肠杆菌科引起的尿路感染。
Int J Antimicrob Agents. 2018 Jan;51(1):155-158. doi: 10.1016/j.ijantimicag.2017.09.013. Epub 2017 Sep 21.
8
Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score study.产超广谱β-内酰胺酶（ESBL）或 AmpC β-内酰胺酶的肠杆菌科细菌引起菌血症的确定性治疗中不使用静脉碳青霉烯类抗生素的抗生素：一项倾向评分研究。
Int J Antimicrob Agents. 2019 Aug;54(2):189-196. doi: 10.1016/j.ijantimicag.2019.05.004. Epub 2019 May 7.
9
Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.β-内酰胺/β-内酰胺酶抑制剂与碳青霉烯类药物治疗产超广谱β-内酰胺酶肠杆菌科血流感染的疗效比较：系统评价和荟萃分析。
Int J Antimicrob Agents. 2018 Nov;52(5):554-570. doi: 10.1016/j.ijantimicag.2018.07.021. Epub 2018 Aug 3.
10
[Urinary tract infection caused by Enterobacteriaceae and its relationship with vesicoureteral reflux].[肠杆菌科细菌引起的尿路感染及其与膀胱输尿管反流的关系]
Bol Med Hosp Infant Mex. 2017 Jan-Feb;74(1):34-40. doi: 10.1016/j.bmhimx.2016.10.011. Epub 2017 Jan 31.

本文引用的文献

1
Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients.不同患者群体中治疗产超广谱β-内酰胺酶肠杆菌科感染的现有选择。
Clin Microbiol Infect. 2019 Aug;25(8):932-942. doi: 10.1016/j.cmi.2019.03.030. Epub 2019 Apr 12.
2
The clinical diagnosis and management of urinary tract infections in children and adolescents.儿童和青少年尿路感染的临床诊断与管理
Paediatr Int Child Health. 2017 Nov;37(4):273-279. doi: 10.1080/20469047.2017.1382046. Epub 2017 Oct 5.
3
Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
非碳青霉烯类抗生素对产超广谱β-内酰胺酶大肠埃希菌所致儿童首次发热性尿路感染的疗效
J Infect Chemother. 2017 Aug;23(8):517-522. doi: 10.1016/j.jiac.2017.04.006. Epub 2017 May 18.
4
The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.非碳青霉烯类β-内酰胺类药物在治疗产超广谱β-内酰胺酶感染中的应用
Clin Infect Dis. 2017 Apr 1;64(7):972-980. doi: 10.1093/cid/cix034.
5
The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.抗流行性质粒和国际高危克隆在多重耐药肠杆菌科细菌传播中的作用
Clin Microbiol Rev. 2015 Jul;28(3):565-91. doi: 10.1128/CMR.00116-14.
6
Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae.产超广谱β-内酰胺酶肠杆菌科细菌所致小儿尿路感染的抗菌治疗结果
Infect Chemother. 2013 Dec;45(4):415-21. doi: 10.3947/ic.2013.45.4.415. Epub 2013 Dec 27.
7
Diagnosis and management of pediatric urinary tract infections.小儿尿路感染的诊断与管理
Clin Microbiol Rev. 2005 Apr;18(2):417-22. doi: 10.1128/CMR.18.2.417-422.2005.